Kavita Singh is a postdoctoral researcher at the Health Economics and Health Financing Unit of the Heidelberg Institute of Global Health, Heidelberg University, Germany. She has a secondary appointment as Senior Research Scientist, Public Health Foundation of India and an Adjunct Faculty at the Hubert Department of Global Health, Emory University, USA. Kavita is an epidemiologist by training and has more than a decade of research experience in global cardiovascular health epidemiology, clinical trials, implementation science, health systems and policy research. Kavita work across the spectrum of cardiovascular disease prevention in research on implementation and evaluation of quality improvement strategies, the interaction between COVID-19 and cardiovascular diseases, and health, psychosocial and economic impacts of COVID-19 on chronic conditions. In 2019, Kavita is the first Indian to receive the NIH Emerging Global Leader Award (K43 grant, 2019-2024), to conduct a study that aims to develop and test the feasibility/effectiveness of a collaborative quality improvement strategy for the secondary prevention of cardiovascular diseases in India.
Scientific background
2016 PhD, All India Institute of Medical Sciences, New Delhi, India
2013 MSc. (Short course) Economic Evaluation, London School of Hygiene and Tropical Medicine, United Kingdom (UK)
2008 MSc. (Clinical Research), Cranfield University, UK
2006 BSc. (Honors) Microbiology, University of Delhi, India
Selected Publications
- Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial. Singh K, Nikhare K, Gandral M, et al. American Heart Journal. 2024;276:83-98. doi:10.1016/j.ahj.2024.07.008
- Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial. Ali MK*, Singh K*, Kondal D, et al. PLOS Medicine. 2024;21(6):e1004335. Published 2024 Jun 3. doi:10.1371/journal.pmed.1004335.
- Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study. Singh K, Kondal D, Mohan S, et. al. BMC Public Health. 2021 Apr 8;21(1):685.
- Collaborative Quality Improvement Strategy in Secondary Prevention of Cardiovascular Disease in India: Findings from a Multi-Stakeholder, Qualitative Study using Consolidated Framework for Implementation Research (CFIR). Singh K, Huffman MD, Johnson LCM, et al. Global Heart. 2022;17(1):72. Published 2022 Oct 11. doi:10.5334/gh.1161
- Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients with Cardiovascular Disease. Singh K, Bawa VS, Venkateshmurthy NS, et al. JAMA Network Open. 2021 Jun 1;4(6):e2113375. URL to full list of publications: I have more than 80 peer-reviewed research publications (h-index: 39). Google scholar: https://scholar.google.co.in/citations?view_op=list_works&hl=en&user=k8C76hwAAAAJ
